Drug Master Files for: alendronate sodium
✉ Email this page to a colleague
alendronate sodium Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
14334 | A | II | 8/6/1999 | CIPLA LTD | ALENDRONATE SODIUM USP |
14983 | I | II | 8/2/2000 | ALCHYMARS SPA | ALENDRONATE SODIUM |
15409 | A | II | 4/30/2001 | APOTEX PHARMACHEM INC | ALENDRONATE SODIUM TRIHYDRATE USP |
15858 | I | II | 2/12/2002 | CHEMI SPA | SODIUM ALENDRONATE |
16129 | A | II | 9/10/2002 | SIGNA SA DE CV | ALENDRONATE SODIUM TRIHYDRATE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information